Investigators assessed whether anticoagulation and platelet aggregation inhibition could have antitumoral effects when used along side targeted therapies for patients with unresectable stage III-IV ...

A new study suggests that retrievable inferior vena cava filters do not further improve outcomes in patients with severe acute pulmonary embolism who receive anticoagulation therapy. Specifically, the ...

Please provide your email address to receive an email when new articles are posted on . Anticoagulant therapy before GCA diagnosis had a protective effect against cranial ischemic complications. Risk ...

Remote screening with a smartwatch detected new-onset atrial fibrillation more often vs. standard care among patients at ...

Credit: Getty Images. MK-2060 is an investigational monoclonal antibody designed to inhibit the activation of Factor XI and its ability to activate downstream proteins. The Food and Drug ...

CHICAGO -- For extended anticoagulation after venous thromboembolism (VTE) in patients with active cancer, a lower dose of apixaban (Eliquis) was just as effective as a higher dose -- and safer, the ...

Researchers at Kumamoto University have developed a highly sensitive blood test that can detect subtle differences in how ...

Dental management in patients taking anticoagulant therapy presents a unique clinical challenge where the risk of excessive bleeding must be balanced against the potential for thromboembolic events if ...

Merck MRK announced that the FDA has granted Fast Track designation to its pipeline candidate, MK-2060, an anticoagulant therapy for the reduction in risk of major thrombotic cardiovascular events in ...

Our extensive research on the United States Anticoagulation Therapy (2024-2032) offers valuable insights for businesses. This comprehensive report delves into emerging trends, inv ...

What is the optimum anticoagulant protocol after thrombectomy (surgical) of the hepatic artery 3 days after living-donor liver transplantation? Although published data does not support one strategy ...